Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gujarat Themis Biosyn Ltd ( (IN:GUJTHEM) ) just unveiled an announcement.
Gujarat Themis Biosyn Ltd has announced that it has published a shareholder notice in the English and Gujarati editions of the Western Times, in line with a recent SEBI circular issued on January 30, 2026. The notice concerns a special window allowing investors to re-lodge transfer requests and dematerialise their physical share certificates.
The company said the newspaper clippings of this notice are also available on its website, ensuring broader access and regulatory transparency for shareholders. By formally informing stock exchanges and publicising the process, Gujarat Themis Biosyn aims to facilitate the transition away from physical shareholding and reinforce compliance with evolving market regulations.
More about Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd is an Indian pharmaceutical and biosciences company based in Vapi, Gujarat, with an additional corporate office in Mumbai. The company operates in the biotech and pharma space, focusing on manufacturing active pharmaceutical ingredients and related products for domestic and possibly export markets.
Average Trading Volume: 10,568
Technical Sentiment Signal: Hold
Current Market Cap: 28.73B INR
For an in-depth examination of GUJTHEM stock, go to TipRanks’ Overview page.